Abstract Desmosomes are cell-cell junctions that mediate adhesion and couple the intermediate filament cytoskeleton to sites of cell-cell contact. This architectural arrangement integrates adhesion and cytoskeletal elements of adjacent cells. The importance of this robust adhesion system is evident in numerous human diseases, both inherited and acquired, which occur when desmosome function is compromised. This review focuses on autoimmune and infectious diseases that impair desmosome function. In addition, we discuss emerging evidence that desmosomal genes are often misregulated in cancer. The emphasis of our discussion is placed on the way in which human diseases can inform our understanding of basic desmosome biology and in turn, the means by which fundamental advances in the cell biology of desmosomes might lead to new treatments for acquired diseases of the desmosome.
Introduction
Biologists have gained substantial insight into desmosome function and regulation from the investigation of diseases in which desmosomal adhesion is disrupted. Affecting nearly every tissue in which desmosomal proteins are expressed, these disorders include inherited, auto-immune, infectious diseases and cancer. Since their first description as Bintercellular bridges^by Giulio Bizzozero in 1864 (Bizzozero 1864; Calkins and Setzer 2007; Mazzarello et al. 2001) , desmosomes have become recognized as sites of strong cell-cell adhesion (Berika and Garrod 2014) . Stemming from the Greek words desmos meaning bond or to bind and soma meaning body, the desmosome is a highly ordered and specialized Bspot-weld^of intracellular adhesion (Cirillo 2014) . Desmosomes are sites of strong adhesion that tether adjacent cells through extracellular adhesive interactions and intracellular linkages to the intermediate filament cytoskeleton. By mechanically anchoring neighboring cells to one another, the desmosome provides tissues with the ability to resist mechanical forces (Kowalczyk and Green 2013) . Desmosomes are prominent in epithelial and cardiac tissues, both of which experience a high degree of mechanical stress (Berika and Garrod 2014; Desai et al. 2009 ). Although essential for tissue integrity, the desmosome is thought to be a dynamic complex that undergoes remodeling during both normal homeostasis and processes such as development, differentiation, wound healing and disease (Kitajima 2013 (Kitajima , 2014 Nekrasova and Green 2013) .
At the ultrastructural level, desmosomes exhibit parallel electron-dense plaques, one from each opposing cell, physically joined in the intracellular space (Fig. 1a, b; Kelly 1966; Odland 1958; Overton 1962) . This electron-dense appearance is attributable to the extensive clustering and tight packing of desmosomal components. Remarkably, desmosomes are also uniform in size, being roughly 0.2-0.5 μm in diameter, depending on the tissue (Kowalczyk and Green 2013) . Thus, desmosomes represent a unique membrane microdomain that is symmetrical and highly ordered. The desmosome is comprised of proteins from three major gene families ( Fig. 1c ; Berika and Garrod 2014; Kowalczyk and Green 2013) . The desmosomal cadherins, desmogleins 1-4 (Dsg) and desmocollins 1-3 (Dsc) are type-1 transmembrane proteins that are members of the cadherin superfamily that mediate calcium-dependent cell adhesion. The cadherins each have four extracellular cadherin repeats (EC1-4; Fig. 1d ), with the EC1-2 domains thought to be primarily responsible for engaging in cis (on the same cell) and trans (on opposing cells) interactions to drive junction assembly (Kowalczyk and Green 2013) . Cadherin cytoplasmic binding partners make up what is commonly referred to as the Bdesmosomal plaque^and include armadillo family members, plakoglobin and plakophilins 1-3. Plakoglobin serves as a bridge between the cytoplasmic tails of the cadherins and the intermediatefilament-binding protein desmoplakin. Desmoplakin is a plakin family member and obligate desmosomal protein that provides the crucial link between intermediate filaments and the desmosomal cadherins through interactions with plakoglobin and plakophilin Kowalczyk and Green 2013) . Together, desmoplakin and the plakophilins drive clustering and lateral interactions between desmosomal cadherin complexes (Kowalczyk and Green 2013) , thus reinforcing the desmosomal plaque and strengthening desmosomal adhesion. Other notable desmosome-associated proteins include corneodesmosin, desmoyokin, Perp, desmocalmin, kertocalmin, kazrin, pinin, POF1B and several other members of the plakin family (Holthofer et al. 2007; Ihrie and Attardi 2005; Jonca et al. 2002; Kowalczyk and Green 2013; Sevilla et al. 2008; Shi and Sugrue 2000; Sonnenberg and Liem 2007) .
Desmosomal proteins have complex expression patterns that are tissue-specific and have been shown to be important for driving epithelial patterning and differentiation (Kowalczyk and Green 2013; Simpson et al. 2011) . The choreographed expression profile within the epidermis is a prime example (Fig. 1e ). Dsg2 and Dsc2, together with plakoglobin and desmoplakin, are common in all desmosome-containing tissues, including simple and stratified epithelia and myocardium. Dsg1, Dsc1, Dsg3 and Dsc3 are primarily expressed in stratified epithelia and are organized in reciprocal but overlapping patterns within the epidermal layers. Plakophilin 1 is primarily expressed in the upper layers, plakophilin 2 is primarily found in the lower layers and plakophilin 3 is found throughout the epidermis (Berika and Garrod 2014; Cirillo 2014; Desai et al. 2009 ). The coordinated interaction among desmosomal proteins and their appropriate expression patterns are thought to be essential for Fig. 1 Desmosome structure, molecular composition and epidermal expression profile. a Electron micrograph of a desmosome in cultured human keratinocytes. Bar 0.5 μm. b Super-resolution immunofluorescence of desmosomes in cultured human keratinocytes displaying the localization of desmoglein 3 (red) and desmoplakin (green). Image acquired with structured illumination microscopy (Nikon N-SIM). Bar 0.5 μm. c Representation of a desmosome (Dsg desmoglein, Dsc desmocollin, PG plakoglobin, PKP plakophilin, DP desmoplakin). d
Desmosomal cadherin domain structure (EC extracellular cadherin repeat, EA extracellular anchor, IA intracellular anchor, ICS intracellular cadherin-like sequence). The desmogleins contain an extended tail comprising of an intracellular proline-rich linker (IPL), five repeat unit domains (RUDs) and a desmogelin terminal domain (DTD). e Desmosomal protein expression pattern in the epidermis (DM desmosome, hDM hemidesmosome) desmosome formation and adhesion. As discussed below, the disruption of desmosome function causes numerous human diseases that are often associated with tissue fragility (Cirillo 2014; Thomason et al. 2010 ).
Acquired desmosomal diseases
The importance of desmosome function is evidenced by numerous genetic and acquired diseases that result when desmosomal adhesion is disrupted. This review will focus largely on acquired desmosomal diseases, which fall into two main categories: epidermal autoimmune disorders and infections (Table 1 ). However, we will also consider the roles of desmosomal genes in tumor biology. Our goal is to highlight the pathomechanisms of specific desmosomal diseases and to integrate our understanding of these pathomechanisms into our broader understanding of the way in which desmosomes contribute to tissue function.
Pemphigus
Pemphigus, stemming from the Greek word pemphix, meaning blister, is a family of diseases characterized by circulating autoantibodies that target desmosomal proteins and compromise cell-cell adhesion (Amagai 2009 (Amagai , 2010 Kneisel and Hertl 2011a ). These relatively rare autoimmune diseases (1-16 new cases per million people per year; Hertl 2011a, 2011b; Ruocco et al. 2013 ) present clinically with mucosal erosions and/or epidermal blisters. The mean age of onset is 50-60 years old, although a younger age of onset is observed for endemic variants of pemphigus (Joly and Litrowski 2011; Rocha-Alvarez et al. 2007 ). Unlike other bullous diseases that require complement fixation and inflammatory cascades (Gammon et al. 1980) , pemphigus autoantibodies directed against the extracellular domains of desmosomal cadherins are necessary and sufficient to cause the loss of keratinocyte adhesion, a process termed acantholysis (Amagai 2010) . This assertion has been demonstrated definitively by three decades of research, in particular through an elegant series of passive transfer experiments with antibodies (IgG) purified from patients ( Table 2) . As discussed below, Passive transfer of patient IgG induces blister formation in neonatal mice Anhalt et al. 1982 IgG4 subclass of autoantibodies are pathogenic Rock et al. 1989 PV IgG purified with Dsg EC domains causes suprabasal acantholysis in mice Amagai et al. 1992 PV sera that is immunoabsorbed with EC domain of Dsg3 is no longer pathogenic Amagai et al. 1994 PF sera that is immunoabsorbed with EC domain of Dsg1 is no longer pathogenic Amagai et al. 1995 Cell Tissue Res (2015 several subtypes of pemphigus are defined by the desmosomal proteins targeted and by the tissues affected. We refer readers to a pair of reviews that provide excellent clinical descriptions and key diagnostic indicators for this family of diseases Hertl 2011a, 2011b) .
Pemphigus vulgaris
Pemphigus vulgaris (PV) is the most common form of pemphigus, accounting for about 70 % of cases. Most cases are sporadic, with a few rare familial cases and a higher incidence rate in Ashkenazi Jewish and Japanese populations (Joly and Litrowski 2011; Rocha-Alvarez et al. 2007 ). PV affects both men and women and age of onset is typically between 40 and 60 years, although a few cases have been observed in children (Ariyawardana et al. 2005; Kneisel and Hertl 2011a) . Treatment with immunosuppressive agents decreases the otherwise high mortality rate of PV patients to 5-10 %. PV is characterized clinically by painful mucosal lesions and histologically by an intra-epidermal cleavage between the basal and spinous layers of the epidermis (Amagai 2010) . In the mucosal dominant form of PV, autoantibodies directed against Dsg3 result in blistering restricted to the oral mucosa in which Dsg3 is the predominant Dsg expressed. In these patients, the skin is uninvolved because Dsg1 is expressed sufficiently in the lower layers of the epidermis to compensate for the loss of Dsg3 function. When both Dsg1 and Dsg3 are targeted by autoantibodies, Dsg1 can no longer compensate in the basal layers of the epidermis and the patients develop skin blisters in addition to oral erosions (mucocutaneous form; Amagai 2010; Mahoney et al. 1999a Mahoney et al. , 1999b Sharma et al. 2007 ). Dscs can be the primary targets in PV (Dmochowski et al. 1993; Hashimoto et al. 1995b; Mao et al. 2010; Rafei et al. 2011) , although these cases are less common. Importantly, the targeting of the extracellular domain of the desmosomal cadherins compromises adhesion and causes tissue fragility. The pathomechanisms by which these autoantibodies cause loss of adhesion are discussed in detail below.
Pemphigus foliaceus
Pemphigus foliaceus (PF) is characterized by superficial epidermal blisters without mucosal involvement. Intra-epidermal blistering in PF results from autoantibodies directed against Dsg1 and thus blistering is restricted to the outer (granular) layer of the epidermis in which Dsg1 is expressed. Most cases of PF are sporadic and account for 20-30 % of pemphigus cases. However, endemic forms of PF (also known as fogo selvagem) occur in regions of Brazil, Columbia and Tunisa (Aoki et al. 2011; Joly and Litrowski 2011) . Brazilian endemic PF patients in particular also generate autoantibodies to Dsc1 and 2 (Dmochowski et al. 1993 ). Relative to PV, those diagnosed with PF typically have a better prognosis, as the lesions are more superficial and do not involve mucous membranes. Importantly, autoantibodies directed against the extracellular domain of Dsg1 cause PF (Amagai et al. 1995) . Thus, PV and PF represent well-characterized autoimmune disorders in which autoantibodies disrupt target antigen function (adhesion) and thereby cause disease.
Paraneoplastic pemphigus
First described in 1990 by Anhalt and colleagues (1990) , paraneoplastic pemphigus (PNP) is a rare variant of pemphigus that typically presents in patients diagnosed with lymphoproliferative disorders, primarily malignancies such as nonHodgkin's lymphoma and chronic lymphocytic leukemia (Allen and Camisa 2000; Yong and Tey 2013) . Age of onset is 45-70 years old but children and adolescents can be afflicted. Although less common than PV or PF, it is the most severe disease within the pemphigus family. PNP is characterized by refractory inflammation of the mouth and lips (Amagai 2010) and extremely painful oral lesions, followed by the development of cutaneous lesions that can affect any body area. This includes the palms and/or soles, a feature that is unusual in other forms of pemphigus (Allen and Camisa 2000) . Conjunctival involvement is more common in PNP than with the other pemphigus variants. Also differing from the other forms of pemphigus, simple squamous epithelia can be involved, with 30-40 % of patients developing pulmonary symptoms (Amagai 2010) . A recent study utilizing the PNP model mouse suggests that the fatal pulmonary symptoms in patients are most likely attributable to ectopic expression of Dsg3 and other epidermal antigens (Hata et al. 2013) . Autoantibodies in PNP are directed against multiple desmosomal proteins, including Dsgs, Dscs, desmoplakin and plakophilins (Futei et al. 2003; Gallo et al. 2014; Hashimoto et al. 1995a; Lambert et al. 2010; Seishima et al. 2004) . Similar to other forms of pemphigus, blistering in this disease can be attributed to autoantibodies directed against Dsgs (Amagai et al. 1998; Nishifuji et al. 2007; Saleh et al. 2012) , particularly the Dsg3 EC2-3 domains (Saleh et al. 2012 ). However, autoantibodies directed against the plakin family including envoplakin and periplakin are useful diagnostic markers that help to distinguish PNP from other forms of pemphigus (Amagai 1999; Amagai et al. 1998; Mahoney et al. 1998; Poot et al. 2013; Probst et al. 2009 ). Importantly, histopathological studies have revealed keratinocyte necrosis with the presence of inflammatory cells into the epidermis, supporting the notion that cell-mediated immunity is an important component of PNP (Yong and Tey 2013) . PNP patient prognosis is poor as these individuals often develop sepsis and organ failure, contributing factors in mortality rates approaching 90 % (Yong and Tey 2013) .
IgA pemphigus
IgA pemphigus is characterized by circulating IgA autoantibodies that target both desmosomal and non-desmosomal components of the keratinocyte cell surface. Histologically, acantholysis and extensive neutrophilic infiltration are observed within the upper layers or all layers of the epidermis (Tsuruta et al. 2011) . Two subtypes of IgA pemphigus have been characterized. In subcorneal pustular dermatosis, Dsc1 is the target antigen. In contrast, Dsg1 and 3 are targets in the intra-epidermal neutrophilic dermatosis subtypes (Kneisel and Hertl 2011b) . Only about 60 cases have been reported and the disease is considered to be less life-threatening than the other variants of pemphigus.
Pathomechanisms of pemphigus: altered desmosome dynamics
Despite it being well-established that blistering is caused by autoantibodies directed against Dsgs (Section Pemphigus; Table 2), the precise pathomechanisms of the disease are not fully understood. Two general hypotheses for explaining pemphigus pathomechanisms have been considered Stanley and Amagai 2006) . First, the direct inhibition of Dsg adhesive interactions might result from autoantibodies sterically interfering with adhesion. Second, cellular responses such as Dsg3 endocytosis, decreased desmosome assembly and/or increased disassembly, activation of various cell signaling pathways and keratinocyte apoptosis have been suggested to be pathogenic. Notably, these mechanisms are not necessarily mutually exclusive. This section discusses pemphigus pathomechanisms in detail and highlights the way that the study of PV in particular is revealing fundamental aspects of desmosome biology and desmosome dynamics. Some of the pathways targeted in pemphigus probably contribute to desmosome homeostasis mechanisms that are altered in other diseases. Thus, therapies developed to treat PV might also prove useful in other diseases characterized by altered desmosome function.
Steric hindrance Dsgs, like other cadherins, are thought to engage in extracellular domain interactions that bridge two cells and mediate cell-cell adhesion. Pemphigus autoantibodies have been hypothesized to cause a loss of adhesion by physically interfering with Dsg adhesive function. Indeed, once a cadherin-type molecule was discovered as the target, patient IgG was suggested to disrupt adhesive interactions directly (Amagai et al. 1991) . Substantial evidence now exists that pemphigus autoantibodies disrupt desmosomal adhesion by directly interfering with Dsg cis (same cell) and trans (opposing cells) interactions. Many of the blister-inducing autoantibodies found in patient sera recognize the amino-terminal Dsg domains that are thought to be responsible for engaging in these adhesive interactions. For example, PV patient IgG that was affinity purified by using the first two cadherin repeats (EC1, EC2) of the Dsg3 extracellular domain induced intra-epidermal blisters when injected into mice (Amagai et al. 1992) or human skin cultures (Bhol et al. 1995) . Competition enzyme-linked immunosorbent assays revealed that nearly 70 % of PF sera and nearly 80 % of PV sera bound to the N-terminal 161 residues of Dsg1 and Dsg3, respectively. The authors further mapped the binding site of pathogenic IgG, defined as autoantibodies that were sufficient to induce acantholysis, to the putative adhesive interface based on structural models of classical cadherins (Sekiguchi et al. 2001) .
Additional epitope mapping studies confirmed that regions within the EC1 and EC2 domains of Dsgs contain the dominant epitopes recognized by pathogenic autoantibodies from both PF (Chan et al. 2010 ) and PV . Recently, the putative cis-binding interface of Dsg3 was found to represent a dominant epitope recognized by pathogenic autoantibodies in patients (Di Zenzo et al. 2012 ). Thus, pemphigus autoantibodies often target the Dsg3 domains that are believed to be most critical for extracellular adhesion, supporting the notion that steric hindrance mechanisms are a significant factor in the disruption of desmosomal adhesion in pemphigus patients. Additional evidence supporting the idea that direct inhibition of adhesion contributes to PV pathogenesis comes from the isolation of single chain (scFv) monoclonal IgG cloned from pemphigus patients and from monoclonal IgG isolated from an active PV mouse model (e.g., AK19, AK23). In both instances, these highly characterized monoclonal reagents were found to target the Dsg3 EC1 domain and to be pathogenic in mouse models of disease (Payne et al. 2005; Tsunoda et al. 2003) . These studies strongly suggest that pemphigus autoantibodies directly inhibit Dsg adhesive interactions. Indeed, both PV IgG and the mouse monoclonal AK23 IgG directly disrupt Dsg3-Dsg3 trans interactions as assessed by using atomic force microscopy (Heupel et al. 2008) , suggesting that at least some portion of IgG in patients acts by steric hindrance. Whether antibodies interfere with heterophilic adhesive interactions between Dsgs and Dscs remains unknown. Further studies with atomic level resolution are needed to define the precise mechanism of desmosomal cadherin adhesion and the manner in which PV IgG might disrupt adhesive interactions at the molecular level.
Beyond steric hindrance As discussed above, steric hindrance of Dsg adhesion is an important factor in pemphigus pathophysiology. Additional mechanisms that are thought to contribute to pemphigus pathogenesis are discussed below.
IgG targeting the Dsg EC3-5 domains play a role in acantholysis As discussed above, PV patient IgG directed against the N-terminal domains of Dsg3 are sufficient to cause the loss of adhesion in various models of disease. However, adsorption of PV IgG to remove anti-EC1 domain IgG only partially abolishes blister formation, indicating that autoantibodies against membrane proximal Dsg3 domains also contribute to pathogenesis (Amagai et al. 1992) . Subsequent studies have demonstrated that the adsorption of patient sera against the entire EC domain of Dsg3 (PV sera) or Dsg1 (PF sera) is required to abolish pemphigus IgG activity completely (Amagai et al. 1994 (Amagai et al. , 1995 Langenhan et al. 2014) . Additionally, nearly 20 % of patient autoantibodies bind to regions of the Dsg3 extracellular domain other than the adhesive EC1 and EC2 domains (Sekiguchi et al. 2001 ). Finally, a rare subset of pemphigus patients with active disease lack autoantibodies that target either EC1 and/or EC2 domains (Saito et al. 2012; Sekiguchi et al. 2001) . Collectively, these data indicate that PV IgG directed against the putative adhesive interfaces of the Dsgs are not required for the disruption of desmosome function and blistering in patients. Thus, other considerations are required to understand the way that these antibodies compromise adhesion.
PV IgG cause alterations in the desmosomal plaque
A study employing post-embedding immunogold-electron micoscopy directly compared the Dsg3−/− mouse with the active PV mouse model (Saito et al. 2009 ). The PV clinical hallmark of suprabasal acantholysis is also observed in the Dsg3−/− mouse, together with split desmosomes containing an intact desmosomal plaque (Koch et al. 1997 ). These observations confirm the importance of Dsg3 in epidermal adhesion and are consistent with the idea that PV autoantibodies disrupt adhesion by directly interfering with the adhesive function of Dsg3 (Koch et al. 1997 ). However, in the PV mouse model, a distinct and measurable shift in the positioning of desmoplakin within the desmosomal plaque was observed. This is an interesting observation, because the simple disruption of Dsg3 trans interactions would be predicted to cause desmosome splitting at the adhesive interface but not necessarily alterations in desmosome organization. The authors speculate that the large shift in desmoplakin localization might be the result of a signaling event or might be mechanistically related to the keratin retraction that has been observed in cell culture models of PV (Bektas et al. 2013; Calkins et al. 2006; Tucker et al. 2014 ). This study highlights that IgGinduced blistering is morphologically and thus mechanistically, distinct from a simple Dsg3 loss of function.
IgG-induced Dsg3 clustering
Altered organization of Dsg3 is emerging as a hallmark feature of pemphigus pathogenesis (Ko and McNiff 2014) and has been observed in pemphigus epidermis for many years (Iwatsuki et al. 1999 ). An analysis of pemphigus patient biopsies has revealed that Dsg1, Dsg3 and plakoglobin are misorganized into a clustered pattern in PV patient epidermis compared with control biopsies (Oktarina et al. 2011) . The authors further demonstrated that bivalent IgG is able to induce clustering but that Fab fragments are not. Clustered IgG and Dsg1 and/ or 3 in PF and PV skin has also been reported and furthermore, desmosome size is reduced in PV patients with skin involvement and with autoantibodies against both Dsg1 and Dsg3 (van der Wier et al. 2014) . The authors concluded that Dsg clustering is a marker for the cadherin that is being targeted but that clustering is unlikely to be part of a pathogenic mechanism. This conclusion is based on the observation of Dsg3 clustering in clinically unaffected epidermis in which desmosome size is also normal. However, desmosomes would not be functionally compromised in uninvolved skin, such as in a mucosal dominant PV patient lacking autoantibodies against Dsg1. Whereas mucosal dominant PV patients have IgG to Dsg3 and therefore Dsg3 is clustered, Dsg1 is likely to compensate for the clustering and loss of function of Dsg3. Thus, additional analysis of Dsg3 clustering in PV patients and in PV model systems is needed to clarify further the pathogenic role of Dsg3 clustering.
In vitro studies of Dsg3 distribution in cultured keratinocytes exposed to PV IgG represent a model system for understanding the way that alterations in the cell surface organization of desmosomal proteins might compromise desmosome function. Following PV IgG treatment, the lateral aggregation of Dsg3 is followed by internalization, suggesting that clustering impairs desmosome dynamics and the stability of cell surface desmosomal cadherins (Sato et al. 2000) . Work by Saito et al. (2012) directly compared the effects of the pathogenic monoclonal IgG AK23 with that of polyclonal IgG isolated from PV patient sera. Upon exposure to AK23, Dsg3 and desmoplakin staining at cell borders is unchanged. In contrast, exposure to PV patient IgG dramatically alters desmosomal protein organization. Similarly, at the ultrastructural level, desmosomes are morphologically intact when exposed to AK23 but highly disorganized and smaller when exposed to PV IgG. However, both AK23 and PV IgG similarly compromise keratinocyte adhesion, suggesting that the monoclonal IgG and PV patient IgG disrupt desmosomal adhesion by different mechanisms. Consistent with this hypothesis, the loss of adhesion in response to PV IgG occurs in a p38 mitogen-activated protein kinase (p38MAPK)-dependent manner, whereas AK23-induced loss of adhesion is independent of p38MAPK signaling.
The observation that patient IgG causes Dsg3 clustering and down-regulation does not exclude the possibility that some portion of PV patient IgG, which represents a polyclonal mixture in each patient, disrupts adhesion by steric hindrance. Indeed, this possibility is likely as several pathogenic monoclonal antibodies have been isolated from PV patients (Di Zenzo et al. 2012; Heupel et al. 2008; Payne et al. 2005; Sharma et al. 2007) . Collectively, these studies suggest that pathogenic monoclonal IgG against Dsg3 disrupt adhesion primarily by steric hindrance, whereas polyclonal patient IgG disrupts adhesion by both steric hindrance and clustering, as well as other mechanisms downstream of IgG ligation of the cadherin. Additional mechanisms that might contribute to PV pathogenesis are discussed in subsequent sections.
Dsg endocytosis and down-regulation
A number of studies provide compelling evidence that Dsg endocytosis and the down-regulation of surface pools of the cadherins occur in response to PV IgG binding (Calkins et al. 2006; Cirillo et al. 2007; Iwatsuki et al. 1989 Iwatsuki et al. , 1999 Jolly et al. 2010; Kitajima 2014; Mao et al. 2011 Mao et al. , 2014 Patel et al. 1984; Sato et al. 2000; Schulze et al. 2012) . After PV IgG treatment in cultured keratinocytes, PV IgG and Dsg3 are rapidly internalized (Aoyama and Kitajima 1999; Calkins et al. 2006; Delva et al. 2008; Jennings et al. 2011; Milner et al. 1989; Sato et al. 2000) . Interestingly, plakoglobin but not desomplakin or the plakophilins, appears to be associated with the majority of these internalized IgG-Dsg complexes (Calkins et al. 2006; Jennings et al. 2011 ). Subsequent to internalization, the PV IgG-Dsg3 complex has been found to traffic to endosomal and lysosomal compartments (Calkins et al. 2006; Jennings et al. 2011 ), leading to a decrease in both cell surface and steady-state Dsg3 levels (Calkins et al. 2006; Jennings et al. 2011; Saito et al. 2012; Yamamoto et al. 2007 ). The Triton-soluble or nondesmosomal pool of Dsg3 appears to be depleted as early as 30 min after exposure to PV IgG, whereas the Tritoninsoluble desmosomal pool begins to decrease by 6 h (Aoyama and Kitajima 1999; Jennings et al. 2011; Sato et al. 2000; Yamamoto et al. 2007 ). Work by Delva et al. (2008) revealed that PV-IgG-induced endocytosis occurs through a clathrin-independent lipid-raft-mediated pathway. Furthermore, the disruption of lipid rafts with cholesterol-perturbing drugs prevents both the reduction in Dsg3 cell surface levels and the loss of keratinocyte adhesion (Delva et al. 2008; Stahley et al. 2014) . Ongoing studies in the Kowalczyk laboratory indicate that PV IgG causes Dsg3 clustering and colocalizes with the early endosomal marker EEA1 in PV patient biopsies (S.N. Stahley, unpublished) . Collectively, these studies suggest that the clustering and destabilization of cell surface pools of Dsg3 are characteristics of keratinocytes exposed to PV IgG in vitro and in patients and that these alterations in Dsg3 localization contribute to PV pathogenesis.
Cell signaling
A growing body of evidence has implicated other cellular responses in pemphigus pathogenesis, including several cell signaling pathways. Epidermal growth factor receptor (EGFR), protein kinase C (PKC), Src, p38MAPK, RhoA, c-myc, heat shock protein 27 (HSP27), acetylcholinesterase receptor (AChR), tumor necrosis factor-alpha (TNFα) and tyrosine kinase pathways have all been implicated in contributing to PV-IgG-induced loss of adhesion (Berkowitz et al. 2005 (Berkowitz et al. , 2006 Williamson et al. 2006) . Although various pathways have been implicated in PV pathogenesis, several laboratories have used both cell culture and mouse models to establish roles for EGFR and p38MAPK signaling in Dsg3 endocytosis and the loss of keratinocyte adhesion in response to PV IgG (Bektas et al. 2013; Berkowitz et al. 2005 Berkowitz et al. , 2006 Jolly et al. 2010; Saito et al. 2012; Sayar et al. 2014) . EGFR is activated in response to the pathogenic IgG AK23, followed by an increase in c-myc levels (Schulze et al. 2012) . Additionally, both HSP27 and p38MAPK are rapidly phosphorylated in response to PV IgG. p38MAPK inhibition prevents HSP27 phosphorylation and cytoskeletal reorganization in cultured keratinocytes (Berkowitz et al. 2005 ) and the loss of adhesion in a mouse model of PV (Berkowitz et al. 2006) . Furthermore, increased phosphorylation of both p38MAPK and HSP27 have been detected in PV patient skin (Berkowitz et al. 2008 ). Experiments in cultured keratinocytes have revealed that EGFR activation is downstream of p38MAPK and that the inhibition of EGFR prevents PV-IgG-induced Dsg3 endoctyosis, keratin retraction and the loss of cell adhesion (Bektas et al. 2013 ). Although p38MAPK has been shown to be upstream of EGFR activation, EGFR inhibitors have also been demonstrated to suppress p38MAPK activity , suggesting interplay between EGFR and p38MAPK signaling in the context of PV pathogenesis.
A role for the actin cytoskeleton in regulating desmosome adhesion in the context of PV pathogenesis has also emerged. Actin disruption by latrunculin exacerbates the effects of PV IgG (Jennings et al. 2011) , whereas stabilization of the actin cytoskeleton by jasplakinolide blunts the effects of PV IgG (Gliem et al. 2010) . Consistent with actin regulatory mechanisms modulating desmosomal responsiveness to PV IgG, several studies have implicated the GTPase RhoA, a key regulator of actin organization, in pemphigus. PV-IgG-induced RhoA inactivation has been found to be p38MAPK-dependent and experimental activation of RhoA prevents the PV-IgG-induced loss of adhesion in both cultured cells and human skin. RhoA activation also prevents the loss of Dsg3 from the cytoskeleton-bound fraction typically observed upon PV IgG treatment (Waschke et al. 2006 ). Recently, adducin was shown to be rapidly phosphorylated at serine 726 in a PKC-dependent and p38MAPK-independent manner in response to PV IgG. Adducin is an actinorganizing protein that is a substrate for PKC and a target for RhoA. The protective effect of RhoA is dependent on the presence of adducin and its phosphorylation . PKC signaling has also been implicated in pemphigus and is activated by PV IgG binding. Activation of PKC causes desmosomes to become calcium-dependent and less adhesive (Osada et al. 1997; Wallis et al. 2000) . Recently, DP has been demonstrated to be phosphorylated in a PKC-dependent manner shortly after PV IgG treatment in cultured keratinocytes (Dehner et al. 2014 ). Collectively, these studies suggest that mechanisms involving Rho A, the actin cytoskeleton and PKC are involved in keratinocyte responses to the PV IgG ligation of Dsg3. An interesting speculation is that the various drugs (e.g., RhoA activation) that protect against the PV-IgG-induced loss of adhesion do so by strengthening other junctional complexes rather than by acting directly on desmosomes. Substantial evidence indicates that the functional status of adherens junctions, which are actin-associated, can influence desmosome assembly and disassembly (Getsios et al. 2004; Gumbiner et al. 1988; Kitajima 2013; Vasioukhin et al. 2000) . A deeper understanding of this crosstalk will be important in the search for new therapeutics that might regulate overall cell-cell contact in the context of pemphigus and other disorders that are characterized by altered cell adhesion, such as cancer (see below).
Desmosome non-assembly vs. disassembly A common theme that has arisen from studies of pemphigus pathomechanisms is that PV IgG alter desmosome assembly and disassembly kinetics (Kitajima 2013 (Kitajima , 2014 . One hypothesis is that autoantibodies bind to and down-regulate non-desmosomal Dsg3, thereby upsetting the balance of Dsg3 exchange into and out of the desmosome (Sato et al. 2000) . The effect of PV IgG on the depletion of non-desmosomal pools of Dsg3 would result in the depletion of desmosomal Dsg3 because of the constitutive exchange of Dsg3 out of desmosomes, thereby leading to desmosomes with weakened adhesive interactions. Support for this hypothesis is manifest in the observation that PV IgG depletes desmosomes of Dsg3 by approximately 80 %, leading to a 40 % reduction in adhesive strength in a dissociation assay (Yamamoto et al. 2007 ). Furthermore, immunoelectronmicroscopic time-course experiments of desmosome assembly suggest that PV IgG-Dsg3 complexes that form outside of the desmosome are excluded from entering the mature desmosome core (Aoyama and Kitajima 1999; Sato et al. 2000) . Overall, these studies support a model in which PV IgG bind to the assembly pool of Dsg3 and prevent these molecules from entering desmosomes, thereby leading to Dsg3-depleted desmosomes, which are vulnerable to mechanical stress (Kitajima 2013 ).
An alternative and complementary hypothesis is that PV IgG drive disassembly by increasing the exchange of Dsg3 out of mature desmosomes. During normal desmosome assembly, the desmosomal cadherin-plakoglobin complex is trafficked to the plasma membrane separately from the desmoplakin-plakophilin complex (Green et al. 2010; Nekrasova and Green 2013) . Once at the surface, the cadherin and plaque complexes are thought to associate to drive desmosomal cadherin clustering and tight packing of desmosomal constituents. A reasonable speculation is that the reverse process occurs during desmosome disassembly and turnover. Post-embedding immunoelectron microscopy has revealed that the majority of IgG in the PV mouse model is localized to desmosomes and is uniformly distributed along the entire length of desmosomes (Shimizu et al. 2004) . Additionally, IgG on the surface of keratinocytes has been found to have a strong affinity for desmosomal structures in vivo (Iwatsuki et al. 1989) . Furthermore, endocytosis of Dsg3-plakoglobin complexes occurs independently from desmoplakin dislocation from the desmosomal plaque in cell culture models of PV. These observations are consistent with the hypothesis that PV IgG target desmosomal pools of cadherin and trigger the disassembly of Dsg complexes. Further support for a desmosome disassembly hypothesis comes from a study involving the use of AK23 isotypes. An experimentally constructed IgM isotype of AK23 was found at the edges of desmosomes and between desmosomes, presumably bound to nondesmosomal Dsg3 but is excluded from the desmosomal core in which AK23 IgG is frequently located. Importantly and unlike the IgG isotype, AK23 IgM is unable to induce blistering in mice, indicating that binding to the desmosomal core is necessary to confer pathogenicity (Tsunoda et al. 2011) . These findings suggest that antiDsg3 IgG and thus PV IgG, are only pathogenic when they bind within the extracellular region of intact desmosomes, consistent with the hypothesis that autoantibodies trigger the disassembly of intact desmosomes. Additional experiments with advanced optical imaging approaches and time-lapse imaging are needed to sort out precisely how assembly and disassembly kinetics are impacted by PV IgG binding to Dsg3.
Model for PV pathomechanisms and therapeutic implications As outlined above, pemphigus research over the past 20 years supports a multifactorial model for pathophysiological mechanisms that result in epidermal blistering, including steric hindrance, endocytosis and cell signaling (Fig. 2) . First, anti-Dsg autoantibodies are clearly necessary and sufficient to disrupt adhesion and cause disease (Table 2) . PV IgG bind to surface pools of Dsg3, causing clustering and disorganization of both desmosomal and non-desmosomal pools of the protein. A subset of the autoantibodies act directly to block Dsg3 adhesive interactions, perhaps by sterically hindering protein interactions, thus weakening cell adhesion. Clustering of surface Dsg3, together with the unbinding of adhesive interactions, increases the rate of raft-mediated internalization and degradation of desmosomal protein complexes.
This depletion of surface Dsg3 further weakens cell-cell adhesion. The physical effects of the antibodies are integrated with IgG-induced alteration of several signaling pathways, including p38MAPK and other pathways outlined above. Disrupted signaling activity serves to feed forward the pathogenic response to the autoantibodies by further weakening adhesive interactions, enhancing endocytosis and/or uncoupling cytoskeletal linkages.
The value of resolving the precise pathogenic mechanisms of pemphigus IgG is the promise of developing more targeted and safer therapies to effectively treat this class of disorders. Corticosteroids and immunosuppressive agents are broad-spectrum treatments that have a wide range of potential side-effects, while also predisposing the patient to infections. In addition to more selective immunological suppression, agents that stabilize and/or enhance desmosome dynamics in favor of strong adhesion might represent an important addition to current therapeutic approaches. Tucker et al. (2014) recently demonstrated that increased expression of the plaque protein plakophilin 1 protects cultured keratinocytes from PV-IgG-induced desmosome disruption and loss of adhesion. This work supports the idea that cytoplasmic molecular interactions within the plaque can be modulated to bolster desmosomal strength to prevent disease. Further, the authors provided evidence that plakophilin 1 expression prompts the transition of calcium-dependent steric hindrance of the adhesive interface and the involvement of cell signaling pathways that collectively contribute to the loss of adhesion and subsequent blister formation desmosomes into calcium-independent hyperadhesive desmosomes, a state typical of fully mature desmosomes in vivo. PKC inhibition has been shown to induce desmosome hyperadhesion (Wallis et al. 2000) . Importantly, hyperadhesive desmosomes are resistant to the effects of PV serum, possibly through mechanisms involving PKC inhibition (Cirillo et al. 2010) . Similarly, expression of a desmoplakin point mutant (S2849G) that exhibits enhanced association with keratin filaments and causes desmosomes to become hyperadhesive (Hobbs and Green 2012) has been shown to ameliorate PVIgG-induced loss of cell adhesion (Dehner et al. 2014) . Collectively, these studies suggest that the reinforcement of desmosomal adhesion through the altered expression of desmosomal genes and/or the exploitation of the ability of the desmosome to achieve hyperadhesion might be an effective strategy to prevent acantholysis in pemphigus.
An additional promising target for therapies is lipid rafts, for which a critical role in regulating desmosomal adhesion is emerging. Membrane rafts, microdomains enriched in sphingolipids and cholesterol, can cluster to form larger ordered domains that function as platforms for various cellular processes including signaling, endocytosis and adhesion (Pike 2006; Simons and Ehehalt 2002; Simons and Sampaio 2011) . Recent studies have supported a role for raft association of desmosomal components in regulating adhesion. All desmosomal proteins have been shown to be raft-associated under normal cell culture conditions (Brennan et al. 2012; Nava et al. 2007; Resnik et al. 2011; Roberts et al. 2014; Stahley et al. 2014) . Functional rafts are also required for desmosome assembly and adhesion (Resnik et al. 2011; Stahley et al. 2014 ). Interestingly, PV-IgG-induced Dsg3 endocytosis occurs through a lipid-raft-mediated pathway (Delva et al. 2008) . Further, raft perturbation through cholesterol depletion has been shown to prevent the entry of Dsg3 into PV-IgG-induced endocytic structures termed Blinear arrays^ (Jennings et al. 2011 ) and the loss of keratinocyte adhesion, in addition to preventing proper assembly during a calcium switch assay . Collectively, these data indicate that raft disruption alters the ability of Dsg3 to traffic normally into and out of the desmosome during both assembly and disassembly, suggesting that raft-targeting drugs might be therapeutic in modulating Dsg3 dynamics to favor the formation of stable desmosomes. Rafts possibly also function as signaling hubs for desmosomal regulatory proteins such as EGFR, p38MAPK and Src, all of which have been found to associate with lipid rafts (Simons and Toomre 2000) . Whether these proteins signal from lipid rafts during PV pathogenesis remains to be elucidated. Nonetheless, raft-perturbing agents have potential to be effective in modulating desmosome responsiveness to pemphigus IgG.
Bullous impetigo/Staphylococcal scalded skin syndrome Bullous impetigo is an infectious skin disease caused by the release of exfoliative toxin (ET) by Staphylococcus aureus. ET is a serine protease that cleaves the extracellular domain of Dsg1 with high specificity. The protease does not cleave Dsg3 or related cadherin family members such as E cadherin and does not appear to have any other substrates (Amagai et al. 2000) . Three types of ETs are produced (ETA, ETB and ETD), all specifically targeting Dsg1, with ETA being the most common. The result of Dsg1 cleavage by these ETs is an intra-epidermal cleavage in the uppermost layers of the epidermis, strikingly similar to the granular layer blister caused by IgG targeting Dsg1 in PF. Primarily affecting children, bullous impetigo is very common and highly contagious. Another infectious skin disease, Staphylococcal scalded skin syndrome (SSSS), also known as Ritter disease, was first described in 1878 by Baron Gottfried Ritter von Rittershain and was soon acknowledged to be a more generalized and severe form of bullous impetigo (Mockenhaupt et al. 2005) . SSSS commonly affects children under age 6, particularly neonates (Amagai 2010) . Adults with chronic renal insufficiency or immunosuppression are occasionally affected. In contrast to bullous impetigo, in which blisters form locally at the site of infection, SSSS presents with blisters at sites distant from the infection because of the systemic circulation of the ET. Typically, both bullous impetigo and SSSS are effectively treated by topical or oral antibiotics to eliminate the underlying infection (Bernard 2008; Hartman-Adams et al. 2014) . Additional treatment of pain and anti-septic measures are undertaken when treating SSSS. Whereas mortality in neonates and children remains low, the management of SSSS in adults often presents a challenge with a mortality rate over 60 % (Patel 2004) .
Cancer
Recent work in cancer biology has revealed striking alterations in desmosomal protein expression patterns in various epithelial-derived tumors. The majority of cancer cases are acquired, with only 5-10 % of cancers being inherited (Anand et al. 2008) . In order to become migratory and metastatic, cells must loosen, rearrange and dissociate their junctions, a process known as epithelial-mesenchymal transition (EMT; Birchmeier et al. 1996) . Anchoring junctions are often down-regulated during tumorigenesis (Birchmeier et al. 1995 (Birchmeier et al. , 1996 Defamie et al. 2014) . Indeed, nearly all desmosomal components have been shown to be mis-regulated in various forms of cancer (Table 3) . Nearly 90 % of acantholytic squamous cell carcinomas display a reduction in at least one desmosomal protein, as assessed by immunofluorescence of tumor sections (O'Shea et al. 2014 ). Dsg2 expression is reduced in familial and gastric cancer (Biedermann et al. 2005; Yashiro et al. 2006) , whereas Dsc2 (Hamidov et al. 2011 ) and Dsc3 (Oshiro et al. 2005 ) is reduced in pancreatic and breast cancers. The loss of Dsc3 is also a contributing factor in skin tumor development and progression in a mouse model (Chen et al. 2013 ). Oropharyngeal tumors have been shown to exhibit reduced expression of desmoplakin (Papagerakis et al. 2009 ), whereas plakophilin 1 is down-regulated in prostatic adenocarcinoma (Breuninger et al. 2010 ) and squamous cell carcinoma (Sobolik-Delmaire et al. 2007) ; plakophilins 2 and 3 are reduced in gastric cancer (Demirag et al. 2011) . Finally, the loss of the recently identified desmosomal protein Perp, a p53/p63 target gene, promotes carcinogenesis in both mouse and cell culture model systems (Beaudry et al. 2010; Dusek et al. 2012; Kong et al. 2013) . Up-regulation of desmosomal genes also occurs in some cancers. Dsg2 overexpression has been documented in squamous cell carcinoma (Brennan and Mahoney 2009; Kurzen et al. 2003) , melanoma (Schmitt et al. 2007 ) and prostate cancer (Trojan et al. 2005) , while Dsg3 overexpression occurs in head and neck cancer (Chen et al. 2007 ). Further, plakophilin 3 has been shown to be upregulated in prostatic adenocarcinoma (Breuninger et al. 2010 ) and lung (Furukawa et al. 2005 ) and breast (Demirag et al. 2012) cancer.
Mechanistic details are beginning to emerge regarding the way in which desmosomal protein levels are altered in cancer. For example, the transcription factor Slug has been associated with reduced expression of Dsg3, Dsc2 and plakophilin 1 in oral squamous cell carcinomas (Katafiasz et al. 2011) . Slug has also been implicated in fibroblast growth factor 1 (FGF-1)-induced alterations in border localization of Dsg1/2 and SCC squamous cell carcinoma, AC adenocarcinoma, N/A not applicable desmoplakin in NBT-II bladder carcinoma cells (Savagner et al. 1997; Thiery and Chopin 1999) . DNA methylation also plays a role in the reduced expression of Dsc1, Dsc2, Dsc3 and desmoplakin in lung cancer (Cui et al. 2012a (Cui et al. , 2012b . Furthermore, the protease kallikrein has been linked to the reduced expression of Dsg1 and Dsg2 in pancreatic adenocarcinoma (Ramani et al. 2008) . Finally, EGFR signaling, in cooperation with metalloprotease-mediated ectodomain shedding, regulates Dsg2 endocytosis in the highly invasive SCC68 cell line (Klessner et al. 2009 ). Overall, the majority of data suggest that desmosomes play tumor-suppressive roles similar to E-cadherin. However, these studies have only begun to uncover the influence of the desmosome in cancer and future studies are needed in order to understand the way that desmosomal components might be used as either prognostic markers or as targets for therapy. Interestingly, some of the therapies derived from studying and treating pemphigus might be translatable to other disorders of desmosome disruption, including cancer. An intriguing example of this possibility is genistein, a soy isoflavone and tyrosine kinase inhibitor that prevents loss of desmosome adhesion in various models of PV (Delva et al. 2008; Marquina et al. 2008; Saito et al. 2012) . Genistein has also shown promise in cancer prevention and treatment, as it reverses promoter hypermethylation of tumor suppressor genes (Mahmoud et al. 2014 ). Interestingly, several desmosomal genes have recently been linked to tumor suppressive activity (Chun and Hanahan 2010; Dusek and Attardi 2011) , with the onset of cancer progression through the methylation of desmosomal genes (Cui et al. 2012a (Cui et al. , 2012b . Genistein has been shown to have anti-cancer effects through the inhibition of tyrosine kinases and the modulation of related cellular pathways (Mahmoud et al. 2014; Nagaraju et al. 2013 ). An interesting speculation is that perhaps one of the many ways in which genistein acts to impede cancer progression is by affecting desmosomal adhesion through pathways similar to its protective effects in pemphigus models.
Other desmosomal diseases
In addition to Dsg1 being a target in bullous impetigo, desmosomal components are now known to be targeted in a variety of infectious conditions. Dsg2 is a receptor for adenovirus serotypes (Ad) 3, 7, 11 and 14, which cause respiratory and urinary tract infections (Amagai and Stanley 2012) . Interaction between Dsg2 and Ad3 triggers EMT-like events that result in the opening of intercellular junctions (Wang et al. 2011) . Dsc2/3 is targeted by Giardia duodenalis, a parasitic protozoan that disrupts the arrangement of tight, adherens and desmosomal junctions of intestinal cells (Maia-Brigagao et al. 2012) . Impaired desmosome formation and a reduction in the epithelial barrier is the result of desmoplakin and plakoglobin down-regulation by Bacillus anthracis lethal toxin in alveolar epithelial cells (Langer et al. 2012) . Furthermore, infection by the enterovirus coxsackievirus B3 (CVB3) leads to cardiac failure by inducing miR-21 expression, which targets the deubiquitinating enzyme YOD1. This change leads to enhanced K48-linked ubiquitination and degradation of desmin, a critical intermediate filament that provides anchorage to the intercalated disc; this ultimately results in desmosome disruption (Ye et al. 2014) . Lastly, ultrastructural analysis has revealed smaller desmosomes in Candida infections of the oral mucosa, although the specific targets remain unknown (Nagai et al. 1992) .
A variety of other acquired conditions in which desmosomal components are targeted have also been described. Dsg1 and 3, the primary targets in PV, are also targets in pemphigus erythematosus, a condition with pathology that overlaps clinically and serologically with PF and lupus erythematosus (Oktarina et al. 2012; Perez-Perez et al. 2012) . In this autoimmune disease, IgG deposition is mainly found in the granular layer of the epidermis, suggesting that Dsg1 is the primary pathogenic autoantigen (Amerian and Ahmed 1985) . Thus, the condition has recently been classified as a variant of PF (Steffen and Thomas 2003) . Additionally, antinuclear antibodies are also present in most patients with pemphigus erythematosus (Kneisel and Hertl 2011a; Perez-Perez et al. 2012; Steffen and Thomas 2003) . In patients with Grover's disease, an itchy acantholytic dermatosis, staining for Dsg1 and/or Dsg3 has been shown to be decreased. Although patients are positive for IgA or IgG autoantibodies, whether the autoantibodies cause the disease remains unclear (Phillips et al. 2013) . Autoantibodies against Dsc3 have been implicated in acquired palmoplantar keratoderma (Bolling et al. 2007 ) and autoantibodies against desmosomal components have also been reported in erythema multiforme (Foedinger et al. 1995 (Foedinger et al. , 1996 (Foedinger et al. , 1998 , a hypersensitivity reaction that is associated with infections or medications. The precise pathomechanism of this disease and the related disorder Stevens-Johnson syndrome is not known but the presence of autoantibodies against desmoplakin is considered characteristic of these diseases. Lastly, reduced numbers of desmosomes have been reported in papular acantholytic dyskeratosis (de Almeida Junior et al. 2001) . Thus, an extensive number of epidermal disorders involve alterations in desmosome morphology and function, although additional research in this area is needed to clarify precisely the way that these changes are related to the clinical presentation of these disorders.
Future directions
The study of acquired diseases has revealed significant insight into both the critical role that desmosomes play in epithelial biology and the fundamental cellular mechanisms that regulate desmosomal adhesion. Nevertheless, many pieces of the puzzle are missing. Little is known about how tissue-specific and differentiation-dependent expression of the desmosomal genes is achieved. Furthermore, the identification of the downstream targets of desmosomal cadherin signaling is needed to shed light on the precise roles that these cadherins play in tissue patterning and development. Although poorly understood, cross-talk clearly occurs between desmosomes and other junctions, including adherens and gap junctions. A better understanding of junctional communication during both normal tissue homeostasis and disease conditions will reveal the manner in which the dynamics of one junction affect the other. These insights will deepen our understanding of the basic cell biology of cell-cell contact and reveal new targets for disease treatments.
Desmosomes exhibit a high level of structural organization and remarkable spatial and temporal control during assembly and disassembly. A combination of structural analyses including X-ray crystallography, nuclear magnetic resonance spectroscopy and cyro-electron tomography have all provided significant insight into the structure of desmosome components and their protein interactions (Al-Amoudi and Frangakis 2008; Al-Jassar et al. 2013; He et al. 2003; Owen et al. 2008; Stokes 2007) . Whereas these techniques have generated an appreciation for the network of protein interactions within the desmosome, the entire macromolecular structure has yet to be visualized at high resolution. Even at low resolution, the entire desmosome still has to be comprehensively analyzed in diseased states. Future studies involving proteomics, advanced optical imaging and atomic level structural approaches are needed to understand the way that desmosomes are organized and the manner in which assembly and disassembly pathways regulate this critically important cell adhesion structure.
